OXFORD - Long distance relationships are always difficult to make work. Yet that is what Artemis Pharmaceuticals GmbH (Cologne, Germany) and Exelixis Pharmaceuticals Inc. (South San Francisco, Calif.) believe they will have to do.
Although the two genomics companies are separate legal entities, they have created an alliance that ties their business plans together so tightly that it may be difficult to see the joins.
"We are managing the companies so that the respective interests are aligned. It is our